Trypanosoma brucei (T. brucei) is responsible for the fatal human disease called African trypanosomiasis, or sleeping sickness. The causative parasite, Trypanosoma, encodes soluble versions of inorganic pyrophosphatases (PPase), also called vacuolar soluble proteins (VSPs), which are localized to its acidocalcisomes. The latter are acidic membrane-enclosed organelles rich in polyphosphate chains and divalent cations whose significance in these parasites remains unclear. We here report the crystal structure of T. brucei brucei acidocalcisomal PPases in a ternary complex with Mg 2؉ and imidodiphosphate. The crystal structure reveals a novel structural architecture distinct from known class I PPases in its tetrameric oligomeric state in which a fused EF hand domain arranges around the catalytic PPase domain. This unprecedented assembly evident from Tb b VSP1 crystal structure is further confirmed by SAXS and TEM data. SAXS data suggest structural flexibility in EF hand domains indicative of conformational plasticity within Tb b VSP1.African trypanosomiasis, commonly known as sleeping sickness, affects ϳ50,000 inhabitants of sub-Saharan Africa yearly (1) with 60 million people at risk of infection (2). Sleeping sickness is caused by two subspecies of T. brucei: T. brucei gambiense and T. brucei rhodesiense. The former alone accounts for ϳ98% of the cases in humans and livestock (1). T. brucei brucei is another subspecies of T. brucei that is used as an experimental model in laboratory to study sleeping sickness, and this parasite infects animals causing a disease called nagana (3). Left untreated, sleeping sickness is fatal, and there are currently two drugs used to treat the initial phase of the disease: suramin and pentamidine. These are employed in treatment of trypanosomiasis caused by T. brucei rhodesiense and T. brucei gambiense infections (4). For the treatment of second or neurological phase, an arsenic-based drug called melarsopol is used. However, this drug causes severe side effects and can sometimes be lethal (5). A newer and much more expensive drug, eflornithine, is effective only against T. brucei gambiense. (6). A combination of another drug, nifurtimox, with eflornithine has been used for treatment, but unfortunately it is not effective against T. brucei gambiense (6). Therefore, there is a pressing case to find new, safe, inexpensive, and broad spectrum drugs for treating sleeping sickness in humans and livestock.Soluble inorganic pyrophosphatase (PPase, EC 3.6.1.1) 3 is a ubiquitous and essential enzyme that hydrolyzes the PP i generated during cellular processes such as DNA replication and protein translation (7-9). Soluble PPases comprise two families that differ in both sequence and structure (10, 11). Family/class I PPases occur in all types of cells from bacteria to humans, whereas class II occurs exclusively in bacteria (11-12). Both classes of enzymes require divalent metal cations for catalysis (13-15). PPases from wide sources have been characterized, but those from Saccharomyces cerevisi...